Videos

Featured

ACC 25: Cardiac Biomarker Analysis from the EARLY TAVR Trial

Brian Lindman

Watch time: 6m 34s
MANIFEST-REDO

Daniel Scherr

Watch time: 12m 52s
LINC 25: 36-Month Update on Aspirex Endovascular Thrombectomy System

Michael Lichtenberg

Watch time: 3m 7s
HFSA 24: The EXPANDed Trial

Mark Ricciardi

Watch time: 4m 24s

Hans-Josef Feistritzer, Carlos Collet

Watch time: 8m 15s (10 videos)
ESC 24 Hot Line Discussion: The RHEIA Trial

Harriette Van Spall, Helene Eltchaninoff

Watch time: 20m 14s

Broadcast

Intervention
TAVI Head-To-Head: Design, Data and Directions for Clinical Practice

Martin Swaans, Vijay Kunadian, , et al

Watch time: 1h 1m 7s
EuroPCR 2024: 5 Trials That Will Change My Practice

Mirvat Alasnag

Watch time: 4m 13s

Laurent Fiorina

View from the Thoraxcenter: ESC Congress 24 Hot Line Preview

Nicolas M Van Mieghem, Joost Daemen

Watch time: 27m 27s
EHRA 24: Ablation Strategies for Repeat Procedures in Recurrent AF

Boris Schmidt

Watch time: 2m 53s
EuroPCR 24: 5-year Results of the SOLVE-TAVI trial

Hans-Josef Feistritzer

Watch time: 4m 31s

Trending

Broadcast

Intervention
Calcium Modification Techniques for Coronary Artery Disease

Rodrigo Bagur, Angela McInerney, Rolf Kreutz, et al

View from the Thoraxcenter: ACC 25 Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Watch time: 39m 2s
Could Acute COVID-19 Infection Ignite Thrombotic Risk?

Naveed Sattar, Philippe Gabriel Steg, Lale Tokgözoğlu et al

Watch time: 35m 13s (4 videos)
ACC 25: The EKSTROM Trial

Matthew J Budoff

Watch time: 2m 46s
ACC 25 Late-Breaking Discussion: The ADVANCE-HTN Trial

Harriette Van Spall, Luke Laffin

Watch time: 17m 26s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
ACC 25 Late-Breaking Discussion: The FRESH-UP Trial

Harriette Van Spall, Roland RJ van Kimmenade

Watch time: 14m 1s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s

Alexis Cutchins, Svetlana Blitshteyn, Rebecca Steinberg et al

ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s

Events

Filter by

EHRA 25: The European Affera Ventricular Arrhythmia Ablation Registry

Frédéric Sacher

Watch time: 3m
EHRA 25: 4 Trials That Will Change My Practice

Luigi Di Biase

Watch time: 2m 53s
EHRA 25: The CONSIDERING-AF Study

Emma Sandgren

Watch time: 4m 33s
ACC 25: 4 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 4m 27s
View from the Thoraxcenter: ACC 25 Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Watch time: 39m 2s
ACC 2025: The CardiAMP-HF Trial

Amish Raval

Watch time: 10m 27s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
EHRA 25: The MORE-CRT MPP Trial

Christophe Leclercq

Watch time: 4m 22s
ACC 25: Cardiac Biomarker Analysis from the EARLY TAVR Trial

Brian Lindman

Watch time: 6m 34s

Latest

Filter by

EHRA 25: The European Affera Ventricular Arrhythmia Ablation Registry

Frédéric Sacher

Watch time: 3m
EHRA 25: 4 Trials That Will Change My Practice

Luigi Di Biase

Watch time: 2m 53s
EHRA 25: The CONSIDERING-AF Study

Emma Sandgren

Watch time: 4m 33s
ACC 25: 4 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 4m 27s
View from the Thoraxcenter: ACC 25 Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Watch time: 39m 2s
Medical Publishing in an Era of Disinformation with Dr Joseph Hill

Joseph A Hill, Harriette Van Spall

Watch time: 25m 8s
ACC 2025: The CardiAMP-HF Trial

Amish Raval

Watch time: 10m 27s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s